Literature DB >> 12202669

Communication in end-of-life cancer care: a comparison of team assessments in three European countries.

Irene J Higginson1, Massimo Costantini.   

Abstract

PURPOSE: To compare team assessments of end-of-life communication in three European countries, and to identify factors associated with problematic communication. PATIENTS AND METHODS: Three prospective cohort studies used similar standardized procedures, and included patients referred to palliative care services in the United Kingdom, Ireland, and Italy. Palliative team care staff assessed three components of communication in the last week of the patient's life-between the patient and family (or those close to them), between professionals and patient and family, and between professionals-using a validated measure. Univariate and multivariate analyses explored the data and tested for relationships between possible explanatory variables and communication.
RESULTS: Data were collected on 1,326 patients, 416 in the United Kingdom, 411 in Ireland, and 499 in Italy. Mean age was 68 years (range, 19 to 95 years), 55% were male, and almost two thirds were married. Team members assessed that communication between patient and family was a moderate or severe problem in the last week of life for 30% to 40% of patients; 10% to 20% had moderate or severe problems recorded for the other two communication items. Problematic communication was associated with respiratory and breast cancers, a shorter time in care, and hospice death. It was also associated with greater spiritual need, need for care planning, and poorer patient and family insight (Spearman's rho > 0.4), but not especially with pain and symptom control, in both univariate and multivariate analyses, both within countries and for all data combined.
CONCLUSION: Severe communication problems were reported by team assessments in up to 40% of patients at the end of life. A multiprofessional approach is needed to recognize and improve this.

Entities:  

Mesh:

Year:  2002        PMID: 12202669     DOI: 10.1200/JCO.2002.11.008

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  11 in total

1.  Persisting differences in truth telling throughout the world.

Authors:  Antonella Surbone
Journal:  Support Care Cancer       Date:  2004-01-16       Impact factor: 3.603

Review 2.  Factors influencing death at home in terminally ill patients with cancer: systematic review.

Authors:  Barbara Gomes; Irene J Higginson
Journal:  BMJ       Date:  2006-02-08

3.  Communication preferences and needs of cancer patients: the importance of content.

Authors:  Antonella Surbone
Journal:  Support Care Cancer       Date:  2006-03-16       Impact factor: 3.603

4.  Rediscovering dignity at the bedside.

Authors:  Irene J Higginson; S Hall
Journal:  BMJ       Date:  2007-07-28

5.  Information to cancer patients: ready for new challenges?

Authors:  Antonella Surbone
Journal:  Support Care Cancer       Date:  2008-02-22       Impact factor: 3.603

Review 6.  Cultural aspects of communication in cancer care.

Authors:  Antonella Surbone
Journal:  Support Care Cancer       Date:  2008-01-15       Impact factor: 3.603

7.  Evaluation and ethical review of a tool to explore patient preferences for information and involvement in decision making.

Authors:  F E M Murtagh; A Thorns
Journal:  J Med Ethics       Date:  2006-06       Impact factor: 2.903

8.  Relationship between three palliative care outcome scales.

Authors:  Irene J Higginson; Nora Donaldson
Journal:  Health Qual Life Outcomes       Date:  2004-11-29       Impact factor: 3.186

9.  Death talk: gender differences in talking about one's own impending death.

Authors:  Bragi Skulason; Arna Hauksdottir; Kozma Ahcic; Asgeir R Helgason
Journal:  BMC Palliat Care       Date:  2014-03-11       Impact factor: 3.234

Review 10.  Communication Needs of Cancer Patients and/or Caregivers: A Critical Literature Review.

Authors:  Jieyu Li; Xingjuan Luo; Qian Cao; Yi Lin; Yinghua Xu; Qiuping Li
Journal:  J Oncol       Date:  2020-05-07       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.